Theratechnologies Secures $75 Million in New Credit Facilities with TD Bank and Investissement Québec

Dec 02, 2024•about 1 year ago

Contract Type

partnership

BiopharmaBiotechnologyHealth Care

Description

Theratechnologies Inc. has closed on a $40 million three-year non-dilutive, senior secured syndicated financing with TD Bank, and has agreed to a $15 million second ranking secured subordinated term loan with Investissement Québec. The net proceeds from the new loans, together with cash on hand, will be used to repay all obligations under the Company’s existing facility with affiliates of Marathon Asset Management, L.P. and to fund business development activities.

Company Information

Company

Theratechnologies

About

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedarplus.ca and on EDGAR at www.sec.gov.

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months